- Mental health
WHO fact sheet on mental health covering risks and protective factors, promotion and prevention, care and treatment, and WHO's work in this area
- Depressive disorder (depression)
WHO fact sheet on depression, providing information on prevalence, symptoms, prevention and contributing factors, diagnosis and treatment, and WHO's work in the area
- Determinants of health
Food and water are the major sources of exposure to both chemical and biological hazards They impose a substantial health risk to consumers and economic burdens on individuals, communities and nations Microorganisms such as salmonella, campylobacter, E coli O157, listeria, cholera
- Anxiety disorders - World Health Organization (WHO)
Anxiety disorders, like other mental health conditions, result from a complex interaction of social, psychological and biological factors Anyone can have an anxiety disorder, but people who have lived through abuse, severe losses or other adverse experiences are more likely to develop one
- Laboratory biosafety manual, 4th edition - World Health Organization (WHO)
This fourth edition of the manual builds on the risk assessment framework introduced in the third edition A thorough, evidence-based and transparent assessment of the risks allows safety measures to be balanced with the actual risk of working with biological agents on a case-by-case basis
- WHO good manufacturing practices for biological products
Good manufacturing practices (GMP) for biological products were first published by WHO in 1992 (1) This current revision reflects subsequent developments that have taken place in science and technology, and in the application of risk-based approaches to GMP (2–14) The content of this document should be considered complementary to the general recommendations set out in the current WHO good
- Ageing and health - World Health Organization (WHO)
Ageing explained At the biological level, ageing results from the impact of the accumulation of a wide variety of molecular and cellular damage over time This leads to a gradual decrease in physical and mental capacity, a growing risk of disease and ultimately death
- WHO Statement on higher than normal incidence of aggregation in . . .
WHO Statement on higher than normal incidence of aggregation in Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus Influenzae Type B vaccine, ready to use (liquid) single-dose presentation, produced by Biological E Limited, India Vaccine Potency and Safety unaffected: WHO recommends continued vaccination
|